NASDAQ | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index.
The underlying index is composed of at least 30 securities of companies in the healthcare sector that have powerful relative strength or momentum characteristics.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| CDTX | Cidara Therapeutics Inc | Healthcare | Biotechnology | 6.74% |
| QURE | Uniqure NV | Healthcare | Biotechnology | 5.41% |
| PRAX | Praxis Precision Medicines Inc | Healthcare | Biotechnology | 4.93% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 4.62% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 4.52% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 4.48% |
| IDXX | IDEXX Laboratories Inc | Healthcare | Diagnostics & Research | 4.46% |
| ROIV | Roivant Sciences Ltd | Healthcare | Biotechnology | 4.33% |
| TERN | Terns Pharmaceuticals Inc | Healthcare | Biotechnology | 4.18% |
| ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 4.12% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 4.10% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 4.03% |
| VKTX | Viking Therapeutics Inc | Healthcare | Biotechnology | 3.93% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 3.89% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 3.87% |
| DVA | DaVita HealthCare Partners Inc | Healthcare | Medical Care Facilities | 3.86% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.79% |
| CELC | Celcuity LLC | Healthcare | Biotechnology | 3.77% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 3.77% |
| NKTR | Nektar Therapeutics | Healthcare | Biotechnology | 3.71% |